"Alanine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL NERVOUS SYSTEM.
| Descriptor ID |
D000409
|
| MeSH Number(s) |
D12.125.042
|
| Concept/Terms |
Alanine- Alanine
- Alanine, L-Isomer
- Alanine, L Isomer
- L-Isomer Alanine
- L-Alanine
- L Alanine
|
Below are MeSH descriptors whose meaning is more general than "Alanine".
Below are MeSH descriptors whose meaning is more specific than "Alanine".
This graph shows the total number of publications written about "Alanine" by people in this website by year, and whether "Alanine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 1 | 1 | 2 |
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 0 | 2 | 2 |
| 2011 | 0 | 2 | 2 |
| 2016 | 2 | 2 | 4 |
| 2017 | 3 | 7 | 10 |
| 2018 | 3 | 12 | 15 |
| 2019 | 1 | 9 | 10 |
| 2020 | 79 | 90 | 169 |
| 2021 | 44 | 77 | 121 |
To return to the timeline, click here.
Below are the most recent publications written about "Alanine" by people in Profiles.
-
Structural Bioinformatics Used to Predict the Protein Targets of Remdesivir and Flavones in SARS-CoV-2 Infection. Med Chem. 2022; 18(3):382-393.
-
Synthetic Attempts Towards Eminent Anti-viral Candidates of SARS-CoV. Mini Rev Med Chem. 2022; 22(2):232-247.
-
A review of remdesivir for COVID-19 in pregnancy and lactation. J Antimicrob Chemother. 2021 12 24; 77(1):24-30.
-
Retrospective evaluation of seven different treatment protocols in hospitalized COVID-19 patients Turk J Med Sci. 2021 12 13; 51(6):2835-2849.
-
Improved Survival Among Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Treated With Remdesivir and Dexamethasone. A Nationwide Population-Based Cohort Study. Clin Infect Dis. 2021 12 06; 73(11):2031-2036.
-
Real-world risk evaluation of remdesivir in patients with an estimated glomerular filtration rate of less than 30 mL/min. Am J Health Syst Pharm. 2021 11 23; 78(23):2101-2102.
-
Impact of remdesivir according to the pre-admission symptom duration in patients with COVID-19. J Antimicrob Chemother. 2021 11 12; 76(12):3296-3302.
-
Sinus Bradycardia in a Pediatric Patient Treated With Remdesivir for Acute Coronavirus Disease 2019: A Case Report and a Review of the Literature. J Pediatric Infect Dis Soc. 2021 Oct 27; 10(9):926-929.
-
What is the role of remdesivir in patients with COVID-19? Curr Opin Crit Care. 2021 10 01; 27(5):487-492.
-
The association of remdesivir and in-hospital outcomes for COVID-19 patients treated with steroids. J Antimicrob Chemother. 2021 09 15; 76(10):2690-2696.